PL360848A1 - Kahalalid F - Google Patents
Kahalalid FInfo
- Publication number
- PL360848A1 PL360848A1 PL36084801A PL36084801A PL360848A1 PL 360848 A1 PL360848 A1 PL 360848A1 PL 36084801 A PL36084801 A PL 36084801A PL 36084801 A PL36084801 A PL 36084801A PL 360848 A1 PL360848 A1 PL 360848A1
- Authority
- PL
- Poland
- Prior art keywords
- kahalalide
- formulation
- formulations
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- RCGXNDQKCXNWLO-GZEKAAEYSA-N kahalalide f Chemical compound CC1OC(=O)C(C(C)C)NC(=O)\C(=C\C)NC(=O)C(CC=2C=CC=CC=2)NC(=O)C(C(C)C)NC(=O)C(C(C)CC)NC(=O)C1NC(=O)C(C(C)CC)NC(=O)C(CCCN)NC(=O)C1CCCN1C(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CCCC(C)C)C(C)C)C(C)O)C(C)C)C(C)C RCGXNDQKCXNWLO-GZEKAAEYSA-N 0.000 title 1
- RCGXNDQKCXNWLO-WLEIXIPESA-N (2r)-n-[(2s)-5-amino-1-[[(2r,3r)-1-[[(3s,6z,9s,12r,15r,18r,19s)-9-benzyl-15-[(2r)-butan-2-yl]-6-ethylidene-19-methyl-2,5,8,11,14,17-hexaoxo-3,12-di(propan-2-yl)-1-oxa-4,7,10,13,16-pentazacyclononadec-18-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxopent Chemical compound N([C@@H](CCCN)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@H]1C(N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)NC(/C(=O)N[C@H](C(=O)O[C@H]1C)C(C)C)=C\C)C(C)C)[C@H](C)CC)=O)C(=O)[C@H]1CCCN1C(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)CCCC(C)C)C(C)C)[C@@H](C)O)C(C)C)C(C)C RCGXNDQKCXNWLO-WLEIXIPESA-N 0.000 abstract 1
- 108010091711 kahalalide F Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/15—Depsipeptides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Superconductors And Manufacturing Methods Therefor (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Carbon And Carbon Compounds (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Liquid Crystal Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24447100P | 2000-10-31 | 2000-10-31 | |
| US60/244,471 | 2000-10-31 | ||
| US24622900P | 2000-11-06 | 2000-11-06 | |
| US60/246,229 | 2000-11-06 | ||
| US34844901P | 2001-10-19 | 2001-10-19 | |
| US60/348,449 | 2001-10-19 | ||
| PCT/GB2001/004821 WO2002036145A2 (en) | 2000-10-31 | 2001-10-31 | Kahalalide f formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL360848A1 true PL360848A1 (pl) | 2004-09-20 |
| PL203676B1 PL203676B1 (pl) | 2009-10-30 |
Family
ID=
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL155297A0 (en) | Kahalalide f formulation | |
| MXPA03005769A (es) | Politrimetilen eter ester amida y uso de la misma. | |
| WO2001070275A3 (en) | Polyglutamic acid-camptothecin conjugates and methods of preparation | |
| AU144678S (en) | Bottle | |
| PT1412384E (pt) | Formulação estável de glp-1 modificado | |
| IL153115A0 (en) | Angiogenesis-modulating compositions and uses | |
| PH12001001235B1 (en) | Novel surfactants and formulations | |
| AU5002301A (en) | Cosmetic compositions comprising exfoliating enzymes and uses thereof | |
| SG148031A1 (en) | Use of cci-779 as an antineoplastic agent | |
| MXPA02012937A (es) | Combinaciones de productos activos con propiedades insecticidas y acaricidas. | |
| AU2001247486A1 (en) | Hair restoration formulation | |
| AU3227700A (en) | Skin sanitizing compositions | |
| GB0101035D0 (en) | Formulation and use thereof | |
| AU2001272615A1 (en) | Amphipathic linear peptides and compositions containing same | |
| AU2001292047A1 (en) | Composition containing an azaphthalocyanine and use | |
| AU2002218195A1 (en) | Silicone rubber formulations and the use thereof | |
| AU2002251801A1 (en) | Composition containing hedychium extract and use thereof | |
| MY133881A (en) | "calcilytic compounds" | |
| AU2001279729A1 (en) | Use of cross-linker and compositions made therefrom | |
| MXPA02007173A (es) | Compuestos calciliticos. | |
| EP1383511A4 (en) | CALCILYTIC COMPOUNDS | |
| AU2001297556A1 (en) | 38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof | |
| AU2001271281A1 (en) | Novel compositions for the expression of the human peptide histidine transporter1 and methods of use thereof | |
| AU7655600A (en) | 1,4-dioxacycloalkane-2-one and 1,4-dioxacycloalkene-2-one | |
| AUPQ760400A0 (en) | Herbical formulations and methods of use thereof |